Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
General Dermatology
•
Pediatric Dermatology
In the era of targeted therapies, are there any specific cytokines that help guide therapy?
Related Questions
What orals or biologics do you reach for in a child with recalcitrant inverse psoriasis in the groin who has tried and failed topical including steroids, pimecrolimus, zoryve, ketoconazole, and tacrolimus?
Would you recommend continuing Accutane in a teenage female who has experienced a drop in calcium to 8.8 and reductions in albumin and protein levels one month into therapy?
How do you approach the management of severe infantile eczema? Which topical corticosteroids do you typically use in this population?
What therapies have you had success with in treating CARP when they have failed minocycline?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
What is your treatment approach to non-uremic calciphylaxis? Which treatment modalities do you combine?
What work up do you pursue for a thorough evaluation in patients that present with a potential diagnosis of dermatitis artefacta?
Do you pursue a cardiac evaluation in all patients with an excised cutaneous myxoma?
For hirsutism or acne, what factors or signs raise a suspicion to order a workup?
How do you dose oral tranexamic acid for melasma?
